Jain Rita Insider Trades

Insider Trading History

Track insider trading activity for Jain Rita. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $19.9k 1,080 shares
Last Trade
Jun 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20k 1,080 shares
$18.48
$18.42
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $992k 26,000 shares
Last Trade
Jun 25, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$886k 26,000 shares
$34.09
$38.17
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $370k 20,100 shares
Last Trade
Jun 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$281k 20,100 shares
$13.96
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $24.7k 1,339 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20k 1,339 shares
$14.93
$18.42
AnaptysBio
AnaptysBio ANAB
Director
Holding Value $344k 5,500 shares
Last Trade
Jan 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$417k 9,500 shares
$43.91
$62.51
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $864k 240,000 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$898k 240,000 shares
$3.74
$3.60
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $3.38k 240,000 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.78k 240,000 shares
$0.03
$0.01
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $19.2k 1,043 shares
Last Trade
Dec 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.9k 1,043 shares
$18.16
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $29k 1,572 shares
Last Trade
Sep 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20k 1,572 shares
$12.71
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $740k 40,200 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$180k 40,200 shares
$4.47
$18.42
AnaptysBio
AnaptysBio ANAB
Director
Holding Value $742k 11,864 shares
Last Trade
Jun 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$171k 7,330 shares
$23.32
$62.51
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $630k 16,500 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$322k 16,500 shares
$19.53
$38.17
AnaptysBio
AnaptysBio ANAB
Director
Holding Value $1.03M 16,510 shares
Last Trade
Jan 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$245k 16,510 shares
$14.83
$62.51
AnaptysBio
AnaptysBio ANAB
Director
Holding Value $0 0 shares
Last Trade
Jun 15, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$30.9k 1,300 shares
$23.77
$62.51
AnaptysBio
AnaptysBio ANAB
Director
Holding Value $283k 4,534 shares
Last Trade
Jun 15, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$108k 4,534 shares
$23.77
$62.51
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $630k 16,500 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$601k 16,500 shares
$36.43
$38.17
AnaptysBio
AnaptysBio ANAB
Director
Holding Value $1.03M 16,510 shares
Last Trade
Jan 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$350k 16,510 shares
$21.19
$62.51
Provention Bio
Provention Bio PRVB
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.65M 66,000 shares
$24.98
$24.98
AnaptysBio
AnaptysBio ANAB
Director
Holding Value $663k 10,600 shares
Last Trade
Apr 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$411k 18,615 shares
$22.09
$62.51
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $653k 17,100 shares
Last Trade
Feb 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$724k 17,100 shares
$42.34
$38.17

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up